This article has Open Peer Review reports available.
N-cadherin expression in malignant germ cell tumours of the testis
© Bremmer et al.; licensee BioMed Central Ltd. 2012
Received: 16 May 2012
Accepted: 3 October 2012
Published: 15 October 2012
Testicular germ cell tumours (TGCTs) are the most common malignancy in young men aged 18–35 years. They are clinically and histologically subdivided into seminomas and non-seminomas. Cadherins are calcium-dependent transmembrane proteins of the group of adhesion proteins. They play a role in the stabilization of cell-cell contacts, the embryonic morphogenesis, in the maintenance of cell polarity and signal transduction. N-cadherin (CDH2), the neuronal cadherin, stimulates cell-cell contacts during migration and invasion of cells and is able to suppress tumour cell growth.
Tumour tissues were acquired from 113 male patients and investigated by immunohistochemistry, as were the three TGCT cell lines NCCIT, NTERA-2 and Tcam2. A monoclonal antibody against N-cadherin was used.
Tumour-free testis and intratubular germ cell neoplasias (unclassified) (IGCNU) strongly expressed N-cadherin within the cytoplasm. In all seminomas investigated, N-cadherin expression displayed a membrane-bound location. In addition, the teratomas and yolk sac tumours investigated also differentially expressed N-cadherin. In contrast, no N-cadherin could be detected in any of the embryonal carcinomas and chorionic carcinomas examined. This expression pattern was also seen in the investigated mixed tumours consisting of seminomas, teratomas, and embryonal carcinoma.
N-cadherin expression can be used to differentiate embryonal carcinomas and chorionic carcinomas from other histological subtypes of TGCT.
Testicular germ cell tumours (TGCTs) are the most common malignancy in young men aged 18–35 years. The incidence of TGCT has been constantly increasing over the last 40 years . TGCTs are clinically and histologically subdivided into seminomas and non-seminomas. Non-seminomas can be further subdivided into embryonal carcinomas (EC), teratomas (TER), yolk sac tumours (YS) and chorionic carcinomas (CC) . Seminomas and non-seminomas originate from intratubular germ cell neoplasia (IGCNU) .
Cadherins are Ca2+-dependent transmembrane glycoproteins belonging to the group of adhesion molecules. More than 80 different members constitute the group of cadherins, such as the well-investigated epithelial, neural and placental cadherins . Cadherins are considered to play a major role in cell-cell contacts, in the development of different organs and also in the genesis of tumours. Furthermore, they function as metastasis-suppressing proteins . Decreased cadherin expression is normally found in cancers and is associated with an increased rate of metastasis .
N-cadherin (CDH2), the neuronal cadherin, is a 140 kD protein and was first identified in mouse brain tissue . It plays an important role in migration, differentiation, embryonic development and metastatic behaviour of tumour cells .The function of N-cadherin is dependent on its association with the actin-cytoskeleton, which is mediated through interactions between the C-terminal region of N-cadherin and the cytoplasmic catenin proteins [9, 10]. N-cadherin has been reported to be expressed in different normal tissues . Furthermore, N-cadherin expression could be identified in benign and malignant neoplastic tissues of epithelial and mesenchymal origin [12–17]. In the present study we analysed the expression of N-cadherin in testicular germ cell tumours.
Tissue samples of primary TGCT
Tumour tissues from orchiectomy specimens were acquired from 113 male patients from the University Medical Centre Göttingen, Germany (mean age = 33.86 years). Tumours were classified and staged on the basis of the WHO classification . In the present study a number of 123 blocks have been tested. Investigated cases included IGCNU (n=20), seminomas (n= 77), embryonal carcinomas (n= 40), teratomas (n=17), chorionic carcinomas (n=4), and yolk sac tumours (n=11). One section was made of each tumour per 0.5 cm tumour diameter. Tumour tissues from each testis were immediately fixed in formalin and embedded in paraffin. In addition, normal testis specimens were analysed (n=28, mean age 35.82 ± 12.41). Ethical approval for using the human material in the present study was obtained from the Ethics Committee of the University Medical Centre Göttingen.
Two independent investigators evaluated all tissue sections considering membranous and cytoplasmic N-cadherin staining and using an immunoreactive staining score (IRS). The percentage of positively stained cells was first categorized using a 0–4 scoring system: Score 0 = 0% positive cells, score 1= less than 10% positive cells, score 2 = 10–50% positive cells, score 3 = 51–80% positive cells and score 4 = > 80% positive cells. The intensity of staining was evaluated on a graded scale (0 = negative; 1 = weak; 2 = intermediate; 3 = strong). For the final IRS, the scores of intensity and staining were multiplied and the mean value per patient was calculated.
Immunohistochemical reactions were performed on 5-μ m formalin-fixed and paraffin-embedded testis tissue sections of the testis. The sections were incubated in citrate buffer (pH 6). For primary antibodies the sections were incubated for 30 minutes at room temperature with monoclonal antibody against N-cadherin diluted at 1:50 (DAKO, Hamburg, Germany). Thereafter the sections were incubated with the biotinylated secondary antibody and the streptavidin alkaline phosphatase (REAL, Dako, Hamburg, Germany). Fast red (Dako) was applied to visualise the sites of immunoprecipitations. Tissue samples were analysed by light microscopy after counterstaining with Meyer’s haematoxylin.
Culture of TGCT cell lines
The human TGCT cell lines used in the present study were NCCIT (CRL 2073, teratocarcinoma), NTERA-2 (CRL 1973, embryonal carcinoma) (both cell lines from American Type Culture Collection, Manassas, VA, USA) and Tcam2 (seminoma) (Department of Developmental Pathology, University of Bonn Medical School, Germany). The explored cell lines were cultured in HEPES-buffered RPMI-1640 (Biochrom, Berlin, Germany) supplemented with foetal calf serum (FCS, 10%; CC Pro, Neustadt, Germany), penicillin (100 IU/ml; Sigma, Munich, Germany), streptomycin (100 μg/ml; Sigma), and L-glutamine (2 mM; Biochrom, Berlin, Germany). The incubation temperature was 37°C in a humid atmosphere with 5% carbon dioxide in the air. Cytospins were prepared for the immunohistochemical analysis.
Immunohistochemical staining for N-cadherin in tumour-free testis, IGCNU and invasive TGCT
Immunreactive score and localization of N-cadherin expression (mb = membrane bounded; c = cytoplasmically) within the investigated testicular neoplasias; note that one tumour sample can obtain more than one histological tumour type
Localisation of N-cadherin expression
10.52 ± 1.96
c > mb
10.8 ± 1.88
c > mb
9.38 ± 2.59
mb > c
7.11 ± 0.99
c > mb
yolk sac tumour
9.90 ± 0.94
c > mb
N-cadherin expression in TGCT cell lines
In young men aged 18 to 35 years, testicular germ cell tumours are the most common malignant tumours. TGCT can be divided into the two groups of seminomas and non-seminomas . Differentiating between seminomas and non-seminomas and also mixed germ cell tumours is important because of their different prognosis and therapy .
N-cadherin plays a crucial role in organ development and is usually expressed in neuronal tissue . It could be shown that a non-tissue-specific expression of N-cadherin in tumours plays a crucial role for cell migration, invasion and metastases . This process is also essential in embryonic development and is called epithelial-mesenchymal transition (EMT) . The EMT stimulates the mobility and invasive capacity of tumour cells and it is associated with tumour progression [22, 23] as well as the development of chemotherapy resistance [24, 25]. In addition, not only a non-tissue-specific expression of N-cadherin, but also the switch from different cadherins to N-cadherin are connected with a poor prognosis [26, 27].
In the present study we observed cytoplasmatic and membranous N-cadherin expression in tumour-free testis, IGCNU, seminomas, yolk sac tumours and in primitive neuronal elements within teratomas. Loojenga et.al and Saito et al. reported that E-cadherin is not expressed in seminomas in most cases [28, 29]. The positive N-cadherin expression in our investigation could be an indication of EMT at least in seminomas. Interestingly, N-cadherin was not expressed in embryonic carcinomas and in components of chorionic carcinoma, as we could show in the present study. In contrast, it could be shown that E-cadherin is expressed in embryonic carcinomas . Hart et al. described a model of tumorgenesis in testis germ cell tumours . In this model non-seminomatous germ cell tumours can arise from IGCNU or from seminomas. It seems that malignant germ cell tumours of the testis without N-cadherin but with positive E-cadherin expression show a differentiation into an embryonic carcinoma or chorionic carcinoma. It would be interesting to see whether the expression of N-cadherin is accompanied by the activation of a corresponding pathway or influence a specific differentiation. Such an analysis would possibly offer insights into the relation between N-cadherin expression and behaviour of the tumour.
Several immunohistochemical markers are known for the differential diagnosis of malignant germ cell tumours. Seminomas are usually positive for placental alkaline phosphatise (PLAP) and CD117 (c-kit) [31–33]. OCT 4 is expressed in seminomas and embryonal carcinomas . Immunohistochemical expression of alpha fetoprotein (AFP) can be used for the diagnosis of yolk sac tumours . Chorionic carcinoma shows an expression of human chorionic gonadotropin . For embryonal carcinoma CD30 positivity in connection with the expression of CD117 usually verifies the diagnosis. Thus N-cadherin expression correlates with the expression pattern of immunohistochemical markers of malignant germ cell tumours such as CD117, PLAP and AFP. Interestingly CD30 and ßHCG are conversely expressed to N-cadherin.
N-cadherin expression can be used to differentiate embryonal carcinomas and chorionic carcinomas from other histological subtypes of TGCT. Thus, loss of N-cadherin possibly influences the differentiation of malignant germ cell tumours.
We thank H. Schorle and D. Nettersheim Department of Developmental Pathology, University of Bonn Medical School, Germany for providing us with the Tcam2-cell lines.
- Rosen A, Jayram G, Drazer M, Eggener SE: Global trends in testicular cancer incidence and mortality. Eur Urol. 2011, 60 (2): 374-379. 10.1016/j.eururo.2011.05.004. Epub 2011/05/27View ArticlePubMedGoogle Scholar
- Horwich A, Shipley J, Huddart R: Testicular germ-cell cancer. Lancet. 2006, 367 (9512): 754-765. 10.1016/S0140-6736(06)68305-0. Epub 2006/03/07View ArticlePubMedGoogle Scholar
- Hoei-Hansen CE, Nielsen JE, Almstrup K, Sonne SB, Graem N, Skakkebaek NE: Transcription factor AP-2gamma is a developmentally regulated marker of testicular carcinoma in situ and germ cell tumors. Clinical cancer research : an official journal of the American Association for Cancer Research. 2004, 10 (24): 8521-8530. 10.1158/1078-0432.CCR-04-1285. Epub 2004/12/30View ArticleGoogle Scholar
- Angst BD, Marcozzi C, Magee AI: The cadherin superfamily: diversity in form and function. J Cell Sci. 2001, 114 (Pt 4): 629-641. Epub 2001/02/15PubMedGoogle Scholar
- Potter E, Bergwitz C, Brabant G: The cadherin-catenin system: implications for growth and differentiation of endocrine tissues. Endocr Rev. 1999, 20 (2): 207-239. 10.1210/er.20.2.207. Epub 1999/04/16View ArticlePubMedGoogle Scholar
- Stemmler MP: Cadherins in development and cancer. Mol Biosyst. 2008, 4 (8): 835-850. 10.1039/b719215k. Epub 2008/07/18View ArticlePubMedGoogle Scholar
- Gumbiner BM: Regulation of cadherin-mediated adhesion in morphogenesis. Nat Rev Mol Cell Biol. 2005, 6 (8): 622-634. Epub 2005/07/19View ArticlePubMedGoogle Scholar
- El Sayegh TY, Kapus A, McCulloch CA: Beyond the epithelium: cadherin function in fibrous connective tissues. FEBS Lett. 2007, 581 (2): 167-174. 10.1016/j.febslet.2006.12.029. Epub 2007/01/16View ArticlePubMedGoogle Scholar
- Takeichi M: The cadherins: cell-cell adhesion molecules controlling animal morphogenesis. Development. 1988, 102 (4): 639-655. Epub 1988/04/01PubMedGoogle Scholar
- Balsamo J, Arregui C, Leung T, Lilien J: The nonreceptor protein tyrosine phosphatase PTP1B binds to the cytoplasmic domain of N-cadherin and regulates the cadherin-actin linkage. J Cell Biol. 1998, 143 (2): 523-532. 10.1083/jcb.143.2.523. Epub 1998/10/24View ArticlePubMedPubMed CentralGoogle Scholar
- Puch S, Armeanu S, Kibler C, Johnson KR, Muller CA, Wheelock MJ: N-cadherin is developmentally regulated and functionally involved in early hematopoietic cell differentiation. J Cell Sci. 2001, 114 (Pt 8): 1567-1577. Epub 2001/04/03PubMedGoogle Scholar
- Abutaily AS, Addis BJ, Roche WR: Immunohistochemistry in the distinction between malignant mesothelioma and pulmonary adenocarcinoma: a critical evaluation of new antibodies. J Clin Pathol. 2002, 55 (9): 662-668. 10.1136/jcp.55.9.662. Epub 2002/08/27View ArticlePubMedPubMed CentralGoogle Scholar
- Thirkettle I, Harvey P, Hasleton PS, Ball RY, Warn RM: Immunoreactivity for cadherins, HGF/SF, met, and erbB-2 in pleural malignant mesotheliomas. Histopathology. 2000, 36 (6): 522-528. 10.1046/j.1365-2559.2000.00888.x. Epub 2000/06/10View ArticlePubMedGoogle Scholar
- Han AC, Peralta-Soler A, Knudsen KA, Wheelock MJ, Johnson KR, Salazar H: Differential expression of N-cadherin in pleural mesotheliomas and E-cadherin in lung adenocarcinomas in formalin-fixed, paraffin-embedded tissues. Hum Pathol. 1997, 28 (6): 641-645. 10.1016/S0046-8177(97)90171-4. Epub 1997/06/01View ArticlePubMedGoogle Scholar
- Laskin WB, Miettinen M: Epithelial-type and neural-type cadherin expression in malignant noncarcinomatous neoplasms with epithelioid features that involve the soft tissues. Arch Pathol Lab Med. 2002, 126 (4): 425-431. Epub 2002/03/20PubMedGoogle Scholar
- Peralta Soler A, Knudsen KA, Tecson-Miguel A, McBrearty FX, Han AC, Salazar H: Expression of E-cadherin and N-cadherin in surface epithelial-stromal tumors of the ovary distinguishes mucinous from serous and endometrioid tumors. Hum Pathol. 1997, 28 (6): 734-739. 10.1016/S0046-8177(97)90184-2. Epub 1997/06/01View ArticlePubMedGoogle Scholar
- Markovic-Lipkovski J, Brasanac D, Muller GA, Muller CA: Cadherins and integrins in renal cell carcinoma: an immunohistochemical study. Tumori. 2001, 87 (3): 173-178. Epub 2001/08/16PubMedGoogle Scholar
- Eble JN: International Agency for Research on Cancer. Pathology and genetics of tumours of the urinary system and male genital organs. Lyon: IARC-Press. 2004, 359: S p-S pGoogle Scholar
- Hatta K, Takagi S, Fujisawa H, Takeichi M: Spatial and temporal expression pattern of N-cadherin cell adhesion molecules correlated with morphogenetic processes of chicken embryos. Dev Biol. 1987, 120 (1): 215-227. 10.1016/0012-1606(87)90119-9. Epub 1987/03/01View ArticlePubMedGoogle Scholar
- Hazan RB, Phillips GR, Qiao RF, Norton L, Aaronson SA: Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J Cell Biol. 2000, 148 (4): 779-790. 10.1083/jcb.148.4.779. Epub 2000/02/23View ArticlePubMedPubMed CentralGoogle Scholar
- Kalluri R: EMT: when epithelial cells decide to become mesenchymal-like cells. J Clin Invest. 2009, 119 (6): 1417-1419. 10.1172/JCI39675. Epub 2009/06/03View ArticlePubMedPubMed CentralGoogle Scholar
- Harada KI, Miyake H, Kusuda Y, Fujisawa M: Expression of epithelial-mesenchymal transition markers in renal cell carcinoma: impact on prognostic outcomes in patients undergoing radical nephrectomy. BJU Int. 2012, -Epub 2012/06/21Google Scholar
- Nieman MT, Prudoff RS, Johnson KR, Wheelock MJ: N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J Cell Biol. 1999, 147 (3): 631-644. 10.1083/jcb.147.3.631. Epub 1999/11/05View ArticlePubMedPubMed CentralGoogle Scholar
- Polyak K, Weinberg RA: Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer. 2009, 9 (4): 265-273. 10.1038/nrc2620. Epub 2009/03/06View ArticlePubMedGoogle Scholar
- Thomson S, Buck E, Petti F, Griffin G, Brown E, Ramnarine N: Epithelial to mesenchymal transition is a determinant of sensitivity of non-small-cell lung carcinoma cell lines and xenografts to epidermal growth factor receptor inhibition. Cancer Res. 2005, 65 (20): 9455-9462. 10.1158/0008-5472.CAN-05-1058. Epub 2005/10/19View ArticlePubMedGoogle Scholar
- Han AC, Soler AP, Knudsen KA, Salazar H: Distinct cadherin profiles in special variant carcinomas and other tumors of the breast. Hum Pathol. 1999, 30 (9): 1035-1039. 10.1016/S0046-8177(99)90220-4. Epub 1999/09/24View ArticlePubMedGoogle Scholar
- Wheelock MJ, Shintani Y, Maeda M, Fukumoto Y, Johnson KR: Cadherin switching. J Cell Sci. 2008, 121 (Pt 6): 727-735. Epub 2008/03/07View ArticlePubMedGoogle Scholar
- Honecker F, Kersemaekers AM, Molier M, Van Weeren PC, Stoop H, De Krijger RR: Involvement of E-cadherin and beta-catenin in germ cell tumours and in normal male fetal germ cell development. J Pathol. 2004, 204 (2): 167-174. 10.1002/path.1614. Epub 2004/09/21View ArticlePubMedGoogle Scholar
- Saito T, Katagiri A, Watanabe R, Tanikawa T, Kawasaki T, Tomita Y: Expression of E-cadherin and catenins on testis tumor. Urol Int. 2000, 65 (3): 140-143. 10.1159/000064859. Epub 2000/10/29View ArticlePubMedGoogle Scholar
- Hart AH, Hartley L, Parker K, Ibrahim M, Looijenga LH, Pauchnik M: The pluripotency homeobox gene NANOG is expressed in human germ cell tumors. Cancer. 2005, 104 (10): 2092-2098. 10.1002/cncr.21435. Epub 2005/10/06View ArticlePubMedGoogle Scholar
- Niehans GA, Manivel JC, Copland GT, Scheithauer BW, Wick MR: Immunohistochemistry of germ cell and trophoblastic neoplasms. Cancer. 1988, 62 (6): 1113-1123. 10.1002/1097-0142(19880915)62:6<1113::AID-CNCR2820620614>3.0.CO;2-0. Epub 1988/09/15View ArticlePubMedGoogle Scholar
- Bentley AJ, Parkinson MC, Harding BN, Bains RM, Lantos PL: A comparative morphological and immunohistochemical study of testicular seminomas and intracranial germinomas. Histopathology. 1990, 17 (5): 443-449. 10.1111/j.1365-2559.1990.tb00766.x. Epub 1990/11/01View ArticlePubMedGoogle Scholar
- Leroy X, Augusto D, Leteurtre E, Gosselin B: CD30 and CD117 (c-kit) used in combination are useful for distinguishing embryonal carcinoma from seminoma. The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society. 2002, 50 (2): 283-285. 10.1177/002215540205000216. Epub 2002/01/19View ArticleGoogle Scholar
- Jones TD, Ulbright TM, Eble JN, Baldridge LA, Cheng L: OCT4 staining in testicular tumors: a sensitive and specific marker for seminoma and embryonal carcinoma. Am J Surg Pathol. 2004, 28 (7): 935-940. 10.1097/00000478-200407000-00014. Epub 2004/06/30View ArticlePubMedGoogle Scholar
- Eglen DE, Ulbright TM: The differential diagnosis of yolk sac tumor and seminoma. Usefulness of cytokeratin, alpha-fetoprotein, and alpha-1-antitrypsin immunoperoxidase reactions. Am J Clin Pathol. 1987, 88 (3): 328-332. Epub 1987/09/01View ArticlePubMedGoogle Scholar
- Suster S, Moran CA, Dominguez-Malagon H, Quevedo-Blanco P: Germ cell tumors of the mediastinum and testis: a comparative immunohistochemical study of 120 cases. Hum Pathol. 1998, 29 (7): 737-742. 10.1016/S0046-8177(98)90284-2. Epub 1998/07/22View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6890/12/19/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.